Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QDCY | ISIN: AU0000105033 | Ticker-Symbol: L6Y
Frankfurt
28.07.23 | 08:15
0,001 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
WELLFULLY LIMITED Chart 1 Jahr
5-Tage-Chart
WELLFULLY LIMITED 5-Tage-Chart

Aktueller Chart WELLFULLY Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
WELLFULLY LIMITED-Investoren interessieren sich auch für diese Wertpapiere
3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve RepairCollaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems' bioprinting system enabled...
► Artikel lesen
3D Systems Announces Significant Strengthening of Balance SheetTransactions permanently retire approximately $88 million of debt, 41% of prior balance, at a meaningful discount to parRefinancing extends maturity with issuance of $92 million Convertible Senior...
► Artikel lesen
3D Systems Reports First Quarter 2025 Financial ResultsROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth...
► Artikel lesen
UltiMaker Unveils the UltiMaker S8, Engineered for Enhanced Productivity and PrecisionThe UltiMaker S8 delivers up to 4x more productivity and improved part quality, without sacrificing security, reliability or ease of use. Combined with new materials in the UltiMaker...
► Artikel lesen
Stratasys Announces Unaudited Preliminary Approximate Fourth Quarter 2024 Financial ResultsMINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate...
► Artikel lesen
Stratasys Launches TrueDent in Europe, Bringing the Benefits of Monolithic Digital Dentures to Dental Labs, Dentists, and Patients TrueDent-D resin is now available in major European markets that require CE marking, with strong customer interest already building Stratasys (NASDAQ: SSYS) has declared that its TrueDent-D resin...
► Artikel lesen
VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ MarketSAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development....
► Artikel lesen
Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing RequirementsSAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
Organovo, Inc.: Organovo Provides Business UpdateSAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen